Skip to main content

Characterization of Users of New Molecular Entities Approved in 2021 in TriNetX: A Descriptive Analysis

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    new molecular entities (NMEs)
    Description

    This analysis aimed to characterize users of 51 new molecular entities (NMEs) that were approved by the FDA in 2021 in the TriNetX Live™ platform. This query ran on January 19, 2024 and the analysis contains two reports: 

    • Report 1: This report contains data from 43 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA Network with No Shift from January 1, 2021 to the most recently available data, January 19, 2024.
    • Report 2: This report contains contains data from 50 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA Network with Minimal Shift from December 18, 2020 to the most recently available data, January 19, 2024.
    Additional Details
    FDA Center
    CDER
    Time Period
    December 18, 2020 - January 19,2024; January 1, 2021- January 19, 2024
    Analysis Type
    TriNetX Analysis
    Population / Cohort
    All Individuals
    Data Sources
    TriNetX USA Network